Pulmonary Delivery of Nanoparticle-Bound Toll-like Receptor 9 Agonist for the Treatment of Metastatic Lung Cancer.

MLA

Perry, Jillian L., et al. “Pulmonary Delivery of Nanoparticle-Bound Toll-like Receptor 9 Agonist for the Treatment of Metastatic Lung Cancer.” ACS Nano, vol. 14, no. 6, June 2020, pp. 7200–15. EBSCOhost, https://doi.org/10.1021/acsnano.0c02207.

APA

Perry, J. L., Tian, S., Sengottuvel, N., Harrison, E. B., Gorentla, B. K., Kapadia, C. H., Cheng, N., Luft, J. C., Ting, J. P.-Y., DeSimone, J. M., & Pecot, C. V. (2020). Pulmonary Delivery of Nanoparticle-Bound Toll-like Receptor 9 Agonist for the Treatment of Metastatic Lung Cancer. ACS Nano, 14(6), 7200–7215. https://doi.org/10.1021/acsnano.0c02207

Chicago

Perry, Jillian L, Shaomin Tian, Nisitha Sengottuvel, Emily B Harrison, Balachandra K Gorentla, Chintan H Kapadia, Ning Cheng, et al. 2020. “Pulmonary Delivery of Nanoparticle-Bound Toll-like Receptor 9 Agonist for the Treatment of Metastatic Lung Cancer.” ACS Nano 14 (6): 7200–7215. doi:10.1021/acsnano.0c02207.